Putnam Investments’s Ventyx Biosciences VTYX Stock Holding History

Putnam Investments’s Portfolio VTYX Stock Details VTYX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-15,942	Closed	-$216K	–	1228
2022 Q1	$216K	Buy	+15,942	New	+$213K	﹤0.01%	1158

Other funds holding VTYX

venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return

Third Point New York $2.08B AUM 27.04% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Putnam Investments's VTYX Position: Q2 2022 in Review

Putnam Investments sold out of Ventyx Biosciences (VTYX) in Q2 2022, closing a stake of 15,942 shares — an estimated $216K sold.

Putnam Investments first reported a position in VTYX in Q1 2022 and held it in 1 quarter. The position peaked at $216K in Q1 2022. 63 funds tracked by Wall St. Rank hold VTYX as of Q2 2022.

Putnam Investments reported no remaining Ventyx Biosciences position as of Q2 2022 after selling out during the quarter.
Putnam Investments sold 15,942 Ventyx Biosciences shares in Q2 2022, an estimated $216K.
Putnam Investments first reported a position in Ventyx Biosciences in Q1 2022 and held it in 1 quarter.
Putnam Investments's Ventyx Biosciences position peaked at $216K in Q1 2022.
63 funds tracked by Wall St. Rank held Ventyx Biosciences as of Q2 2022.

Based on Putnam Investments's 13F filing for Q2 2022, filed 15 Aug 2022.